Overview

  • Product name
  • Description
    Goat polyclonal to SUMF1
  • Tested applications
    Suitable for: WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat, Cow, Dog
  • Immunogen

    Synthetic peptide:

    C-ETLNPKGPPSGKDR

    , corresponding to internal sequence amino acids 314-327 of Human SUMF1 (NP_877437.2).

  • Positive control
    • Mouse pancreas, Mouse eye and Human kidney lysates

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.
  • Storage buffer
    Preservative: 0.02% Sodium Azide
    Constituents: 0.5% BSA, Tris buffered saline, pH 7.3
  • Concentration information loading...
  • Purity
    Immunogen affinity purified
  • Purification notes
    ab91479 is purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab91479 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notes
    WB: Use at a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 37 kDa (predicted molecular weight: 40 kDa).


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Function
      Using molecular oxygen and an unidentified reducing agent, oxidizes a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also called C(alpha)-formylglycine. Known substrates include GALNS, ARSA, STS and ARSE.
    • Tissue specificity
      Ubiquitous. Highly expressed in kidney, pancreas and liver. Detected at lower levels in leukocytes, lung, placenta, small intestine, skeletal muscle and heart.
    • Pathway
      Protein modification; sulfatase oxidation.
    • Involvement in disease
      Defects in SUMF1 are the cause of multiple sulfatase deficiency (MSD) [MIM:272200]. MSD is a clinically and biochemically heterogeneous disorder caused by the simultaneous impairment of all sulfatases, due to defective post-translational modification and activation. It combines features of individual sulfatase deficiencies such as metachromatic leukodystrophy, mucopolysaccharidosis, chondrodysplasia punctata, hydrocephalus, ichthyosis, neurologic deterioration and developmental delay. Inheritance is autosomal recessive.
    • Sequence similarities
      Belongs to the sulfatase-modifying factor family.
    • Post-translational
      modifications
      N-glycosylated. Contains high-mannose-type oligosaccharides.
    • Cellular localization
      Endoplasmic reticulum lumen.
    • Information by UniProt
    • Database links
    • Alternative names
      • MGC150436 antibody
      • AAPA3037 antibody
      • C alpha formylglycine generating enzyme 1 antibody
      • C-alpha-formylglycine-generating enzyme 1 antibody
      • FGE antibody
      • FGly generating enzyme antibody
      • MGC131853 antibody
      • Sulfatase modifying factor 1 [Precursor] antibody
      • Sulfatase-modifying factor 1 antibody
      • SUMF1 antibody
      • SUMF1_HUMAN antibody
      • UNQ3037 antibody
      see all

    Images

    References

    ab91479 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab91479.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up